[go: up one dir, main page]

AU2003303963A1 - Drug target - Google Patents

Drug target

Info

Publication number
AU2003303963A1
AU2003303963A1 AU2003303963A AU2003303963A AU2003303963A1 AU 2003303963 A1 AU2003303963 A1 AU 2003303963A1 AU 2003303963 A AU2003303963 A AU 2003303963A AU 2003303963 A AU2003303963 A AU 2003303963A AU 2003303963 A1 AU2003303963 A1 AU 2003303963A1
Authority
AU
Australia
Prior art keywords
drug target
drug
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003303963A
Other languages
English (en)
Other versions
AU2003303963A8 (en
Inventor
Ivan Plavec
Oksana Sirenko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioseek LLC
Original Assignee
Bioseek LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioseek LLC filed Critical Bioseek LLC
Publication of AU2003303963A8 publication Critical patent/AU2003303963A8/xx
Publication of AU2003303963A1 publication Critical patent/AU2003303963A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003303963A 2002-12-20 2003-12-19 Drug target Abandoned AU2003303963A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43584802P 2002-12-20 2002-12-20
US60/435,848 2002-12-20
PCT/US2003/040752 WO2004087044A2 (fr) 2002-12-20 2003-12-19 Cible medicamenteuse

Publications (2)

Publication Number Publication Date
AU2003303963A8 AU2003303963A8 (en) 2004-10-25
AU2003303963A1 true AU2003303963A1 (en) 2004-10-25

Family

ID=33131511

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003303963A Abandoned AU2003303963A1 (en) 2002-12-20 2003-12-19 Drug target

Country Status (2)

Country Link
AU (1) AU2003303963A1 (fr)
WO (1) WO2004087044A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1872293A4 (fr) * 2005-03-28 2010-01-06 Bioseek Inc Etablissement de profils d'ensembles de donnees biologiques de maladie cardio-vasculaire et d'inflammation cardio-vasculaire

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007094A1 (fr) * 1990-10-16 1992-04-30 The Regents Of The University Of Michigan Marqueur de reponse inflammatoire induit par la cytokine
WO2002002807A2 (fr) * 2000-06-30 2002-01-10 Epigenomics Ag Diagnostic des maladies associees a la signalisation cellulaire

Also Published As

Publication number Publication date
WO2004087044A2 (fr) 2004-10-14
AU2003303963A8 (en) 2004-10-25
WO2004087044A3 (fr) 2005-02-17

Similar Documents

Publication Publication Date Title
AU2003291103A1 (en) Pharmaceutical composition
AU2003221497A1 (en) Pharmaceutical microparticles
AU2003242381A1 (en) Radar
AU2003215209A1 (en) Syringe
AU2003901813A0 (en) Pharmaceutical derivatives
AU2003250372A1 (en) Pharmaceutical composition
AU2003259457A1 (en) Auto-destructible syringe
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2003225652A1 (en) Bullet
AU2003215150A1 (en) Therapeutic compounds
AU2003264406A1 (en) Drug or cosmetic
AU2003241137A1 (en) Bullet
AU2003255727A1 (en) Syringes
AU2003246971A1 (en) Tranquilliser dart
AU2003303963A1 (en) Drug target
AU2003254043A1 (en) Antifungal therapeutic targets
AU2003281861A1 (en) Target dna
AUPS188302A0 (en) Pharmaceutical composition
AUPS243002A0 (en) Therapeutic target and uses thereof
AU2003268985A1 (en) Cannula
HK1072601A (en) Pharmaceutical combination
AU2003238900A1 (en) Pharmaceutical formulation
AU2003296273A1 (en) Neutron-producing target device
AU2003207055A1 (en) Novel drugs for external use
AU2003242346A1 (en) Drug composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase